Brain Tumor Foundation, Tug McGraw Foundation, BrainLAB Unite In Support Of Patient Education

Armen Hareyan's picture
Advertisement

Brain Tumor

More than 200,000 people in the United States are diagnosed with a primary or metastatic brain tumor each year. As the need for more effective treatment increases, so does research into improving treatment technology.

Today, the National Brain Tumor Foundation (NBTF) and The Tug McGraw Foundation partnered with BrainLAB and other medical leaders in the field of brain tumor treatment, to discuss the latest treatment options available and provide patients with the information they need to make the right choices with their physicians.

"In addition to funding research, we also provide support and information to brain tumor patients and their families. We work to raise awareness around advancements in treatment technology," said Robert Tufel, MSW, MPH, Executive Director, NBTF. "Empowering patients through education helps them gain a better understanding of their disease, so they can take an active role in their treatment."

Brain tumors are the second leading cause of cancer deaths in males aged 20-29 and the fifth leading cause of cancer deaths in females aged 20-39. With the evolution of radiosurgery, chemotherapy, convection enhanced drug delivery and traditional surgical methods, brain tumor patients need to better understand all treatment options available to them so they can make informed decisions.

"Our mission is to raise awareness of brain cancer and pioneer the latest treatments for the disease," said Jennifer Brusstar, President and CEO, The Tug McGraw Foundation. "Patient education programs like this give us the opportunity to provide patients and their families with vital information, while also creating new partnerships."

This free educational program "Advanced Treatment Options for Brain Tumors: Radiosurgery and the Latest Technologies," which took place today at The Fairmont in Washington D.C., was aimed at brain tumor patients and their families and designed to shed light on existing treatment options with a focus on the following areas:

-- Understanding brain tumors

Advertisement

-- Principles of radiosurgery

-- Treatment options for brain tumors

-- How to cope with a brain tumor

Attendees were given the opportunity to speak directly with some of the top brain tumor specialists in the country who presented at the program, including:

-- David W. Andrews, MD, from Thomas Jefferson University Hospital

-- Walter Curran, MD, from Thomas Jefferson University Hospital

-- John M. Sampson, MD, PhD, from Duke University Medical Center

"As a leading provider of advanced technology for brain tumor treatment, we view our partnership with NBTF and The Tug McGraw Foundation as a natural fit," said Jean Hooks, General Manager Oncology Solutions, BrainLAB. "Our goal is to help patients learn more about their disease, the latest treatment options, and what to expect during and after treatment."

The program also kicks off a BrainLAB fund-raising effort benefiting NBTF and The Tug McGraw Foundation through GoodSearch.com -- a search engine that donates 50 percent of its revenue to charities designated by its users. Through GoodSearch, BrainLAB has created an innovative way for its employees to participate in the socially responsible initiatives of the company. Each time its employees search the Internet, a donation will be made by GoodSearch to the foundations.

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.
Advertisement